Natixis Investment Managers International Stryker Corp Transaction History

Natixis Investment Managers International

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$194.09 - $276.37 $479,402 - $682,633	2,470 Added 13.2%	21,187 $4.21 Million
Q1 2022 May 13, 2022	BUY	$245.33 - $277.77 $4.59 Million - $5.2 Million	18,717 New	18,717 $5 Million
Q4 2018 Feb 14, 2019	SELL	$145.0 - $178.65 $952,360 - $1.17 Million	-6,568 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$163.25 - $177.68 $462,160 - $503,012	2,831 Added 75.76%	6,568 $1.17 Million
Q2 2018 Aug 14, 2018	BUY	$155.17 - $179.78 $425,786 - $493,316	2,744 Added 276.33%	3,737 $631,000
Q1 2018 May 15, 2018	BUY	$148.01 - $168.91 $146,973 - $167,727	993 New	993 $160,000
Q3 2017 Nov 14, 2017	SELL	$138.36 - $147.87 $1.27 Million - $1.35 Million	-9,145 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	9,145	9,145 $1.27 Million

2,228

285M

1.35M

1.6M

Ticker SYK
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 378,320,992
Market Cap $148B
Description
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products c...

Get notified when there are updates to the investment portfolio of Natixis Investment Managers International, based on Form 13F filings with the SEC.

Stay updated on Natixis Investment Managers International with notifications on news.